News
MDT
78.70
+0.31%
0.24
DexCom reaches a multi-year low as downgrades follow guidance cut
Seeking Alpha · 5h ago
S&P 500's Biggest Loser Has a Heart Valve Problem
The Wall Street Journal · 1d ago
With 87% institutional ownership, Medtronic plc (NYSE:MDT) is a favorite amongst the big guns
50% of Medtronic plc is held by the top 23 shareholders of the company. The company has 87% of its shares held by institutions. The majority of shares are held by institutional investors, but the company is not owned by hedge funds. In a similar way, institutions own more than half of the business. Medtronics plc has a history of insider buying and selling of shares. It's worth looking at the insider ownership of a company to see if there are any warning signs for shareholders.
Simply Wall St · 2d ago
My Dividend Stock Portfolio: New June Dividend Record - 101 Holdings With 22 Buys
My Dividend Stock Portfolio hit a new record of 101 Holdings With 22 Buys in June. In June, Stefan Redlich added $131 to his yearly dividend income of $1.7 million. He is aiming to increase dividend income by at least $100 each month. Main portfolio picks included Ares Capital, Hercules Capital, and Goldman Sachs BDC.
Seeking Alpha · 2d ago
Watchman In Focus As Boston Scientific Reports Its Q2
NASDAQ · 2d ago
LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Seeking Alpha · 3d ago
Up 25% This Year, Will The Solid Q2 Performance Help Intuitive Surgical Stock Extend Its Winning Streak?
NASDAQ · 3d ago
Weekly Report: what happened at MDT last week (0715-0719)?
Weekly Report · 4d ago
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott will use guerilla marketing to promote the U.S. Launch of its glucose monitoring device Lingo. The device targets consumers without diabetes and aims to personalize health data. The company will use TV ads and other methods to promote Lingo in the United States.
Benzinga · 07/19 15:10
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Baird analysts outlined stocks within medical technology where they see an upside during the second quarter’s earnings. Healthcare and med-tech has underperformed the broader market year-to-date. Med-tech was up 3.4% and the U.S. Health care sector was up 8.8%.
Seeking Alpha · 07/18 15:34
Johnson & Johnson’s Q2 Profit Beats Forecasts on Drug Sales
NASDAQ · 07/17 23:49
Down 7% This Year Will Abbott Stock See Higher Levels Post Q2 Results?
NASDAQ · 07/17 16:33
MDT Factor-Based Stock Analysis
NASDAQ · 07/17 16:11
Medtronic (MDT) Receives a Hold from RBC Capital
TipRanks · 07/17 15:49
Medtronic Price Target Maintained With a $92.00/Share by RBC Capital
Dow Jones · 07/17 14:43
RBC Capital Reiterates Sector Perform on Medtronic, Maintains $92 Price Target
Benzinga · 07/17 14:34
Medtronic: Lock In This Dividend Aristocrat While It's Still Cheap
Medtronic plc is a strong dividend aristocrat with top-line growth, profitability, and new product opportunities in the healthcare tech sector. The company has raised its dividend for 47 consecutive years. Medtronic is a good value stock with strong financials, dividend growth, and potential for market-beating returns.
Seeking Alpha · 07/17 12:40
What 8 Analyst Ratings Have To Say About Medtronic
Medtronic (NYSE:MDT) underwent analysis by 8 analysts in the last quarter. The company has an average price target of $88.25. The 12-month price targets of Medtronic's stock offer insights into the company's future prospects. The medical-device company develops and manufactures therapeutic medical devices for chronic diseases.
Benzinga · 07/16 17:01
Medtronic Price Target Cut to $85.00/Share From $88.00 by Truist Securities
Dow Jones · 07/16 14:02
More
Webull provides a variety of real-time MDT stock news. You can receive the latest news about Medtronic through multiple platforms. This information may help you make smarter investment decisions.
About MDT
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.